Medicare Enrolled
Dr. Niranjan Shrestha, M.D., FAAFP
Family Medicine · Centralia, IL
Practice pattern: Clinical Cardiology
— Primarily office-based clinical cardiology
Low-engagement
Very High
DATA COVERAGE
Data in 4 of 4 federal sources
Measures public federal data availability — not provider quality
Informational, not a quality rating.
This page presents federal public records about Dr. Shrestha from CMS (NPPES, Open Payments, Medicare Provider Utilization, PECOS). It is not medical advice, an endorsement, or a judgment of clinical quality. Always consult the provider directly and a licensed clinician for medical decisions. Read methodology →
Are you Dr. Shrestha?
Request a correction or review of any data shown here. Provider portal →
What this data tells you about Dr. Shrestha
Dr. Niranjan Shrestha is a family medicine specialist in Centralia, IL, with 18 years of NPI registration. Based on federal Medicare data, Dr. Shrestha performed 2,367 Medicare services across 893 unique beneficiaries.
Between the years covered by Open Payments, Dr. Shrestha received a total of $13,187 from 54 pharmaceutical and/or device companies across 838 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common in family medicine. Most payments are for meals and travel — low-value interactions common across virtually all practicing physicians. Patients may wish to discuss these relationships with their provider.
The Data Coverage level for Dr. Shrestha is Very High — reflecting how much public federal data is available about this provider. Patients are encouraged to use this data as one of several factors when choosing a healthcare provider.
✓ 18 years in practice
▲ Top 7% volume in IL
$13,187 industry payments
Medicare Practice Summary
Medicare Utilization ↗2,367
Medicare services
Top 7% in IL for family medicine
893
Unique beneficiaries
$71
Avg. Medicare payment
Medicare patients only (65+ / disabled) · How to read this →
~132 Medicare services per year of practice
Top procedures by volume
Ranked by number of services performed for Medicare patients. Avg. submitted charge is what the provider billed; avg. Medicare payment is what CMS paid.
| Procedure | Volume | Avg. paid | Avg. submitted |
|---|---|---|---|
| Office visit, established patient (20-29 min) An office visit for an existing patient lasting between 20 and 29 minutes. The visit involves medical evaluation and management of the patient's condition. |
754 | $64 | $210 |
| Office visit, established patient (30-39 min) A follow-up office visit for an existing patient lasting between 30 and 39 minutes. The visit involves medical evaluation and management of the patient's condition. |
565 | $89 | $240 |
| Hospital follow-up visit, moderate complexity Follow-up hospital visit for an existing patient involving moderate medical decision making. The visit requires at least 35 minutes of time spent on the date of service. |
412 | $62 | $210 |
| Hospital discharge day management, 30 minutes or less This service covers the final day of hospital care when the patient is being discharged. It includes coordination of care and instructions for the patient within a time frame of 30 minutes or less. |
176 | $62 | $240 |
| Initial hospital admission, moderate complexity Initial hospital inpatient or observation care for a new patient involving moderate-level medical decision making, with at least 55 minutes total time on the date of the encounter. |
94 | $102 | $380 |
| Nursing facility visit, low complexity A daily follow-up visit for an existing patient in a nursing facility involving straightforward medical decision making. The visit requires at least 15 minutes of time if time is used to determine the level of care. |
81 | $55 | $120 |
| Quadrivalent influenza vaccine, cell-culture derived A flu shot containing four strains of influenza virus, produced using cell culture technology rather than eggs. This formulation is free from preservatives and antibiotics. |
73 | $33 | $55 |
| Flu vaccine administration This procedure involves the administration of the influenza virus vaccine. It covers the process of delivering the vaccine to the patient. |
73 | $30 | $45 |
| Initial hospital admission, high complexity Initial hospital inpatient or observation care for a new patient involving high-level medical decision making, with at least 75 minutes total time on the date of the encounter. |
60 | $135 | $400 |
| Hospital follow-up visit, high complexity Subsequent hospital inpatient or observation care for an existing patient involving high-level medical decision making, with at least 50 minutes total time on the date of the encounter. |
34 | $93 | $230 |
| Nursing facility visit, moderate complexity A follow-up visit by a healthcare provider at a nursing facility for an established patient. The visit involves moderate medical decision making and takes at least 30 minutes. |
33 | $80 | $150 |
| New patient office visit (45-59 min) An initial office visit for a new patient lasting between 45 and 59 minutes. This code covers the total time spent by the physician or qualified healthcare professional on the date of the encounter. |
12 | $97 | $370 |
How to read this data: This reflects Medicare patients only (typically 65+). Payment amounts are what Medicare paid the provider, not your out-of-pocket cost. A higher procedure volume generally indicates more experience with that procedure.
Industry Payment Transparency
Open Payments through 2024 ↗$13,187
Total received (2018-2024)
Avg $1,884/year across 7 years
Top 2% in IL for family medicine
A higher payment rank reflects disclosed industry relationships (consulting, research, speaking) common among subspecialists — not wrongdoing.
54
Companies
838
Individual payments
All payments are legal and publicly reported · Not evidence of wrongdoing · How to interpret →
Payment profile
Industry payments classified by relationship type. Not all payments are equal — research and consulting reflect different relationships than speaking programs or meals.
Meals & Travel
Food, beverages, travel, and lodging — typically low-value
$12,928 (98.0%)
Speaking / Promotional
Speaker programs, honoraria, and industry-sponsored educational events
$159 (1.2%)
Consulting
Expert advisory fees, typically reflecting recognized clinical expertise
$100 (0.8%)
Payment trend by year
Annual totals from pharmaceutical and medical device companies.
2024
$710
2023
$1,387
2022
$2,013
2021
$2,687
2020
$1,730
2019
$2,498
2018
$2,162
Payments by company (2024)
Consulting
Speaking
Meals & Travel
Research
AstraZeneca Pharmaceuticals LP
$201
Lilly USA, LLC
$196
Mylan Specialty L.P.
$76
Bayer Healthcare Pharmaceuticals Inc.
$46
GlaxoSmithKline, LLC.
$27
Azurity Pharmaceuticals, Inc.
$24
Janssen Pharmaceuticals, Inc
$22
PFIZER INC.
$20
Kowa Pharmaceuticals America, Inc.
$18
Axsome Therapeutics, Inc.
$18
Esperion Therapeutics, Inc.
$16
Medtronic, Inc.
$16
Novo Nordisk Inc
$15
Salix Pharmaceuticals, a division of Bausch Health US, LLC
$15
Top 3 companies account for 66.6% of 2024 payments
All-time payments by company (2018-2024) ›
AstraZeneca Pharmaceuticals LP
$1,879
GlaxoSmithKline, LLC.
$1,658
Lilly USA, LLC
$1,179
Novo Nordisk Inc
$1,013
Mylan Specialty L.P.
$686
PFIZER INC.
$540
Kowa Pharmaceuticals America, Inc.
$531
Amgen Inc.
$520
Takeda Pharmaceuticals U.S.A., Inc.
$477
AbbVie Inc.
$472
Boehringer Ingelheim Pharmaceuticals, Inc.
$457
Amarin Pharma Inc.
$326
Janssen Pharmaceuticals, Inc
$325
Salix Pharmaceuticals, a division of Bausch Health US, LLC
$319
Novartis Pharmaceuticals Corporation
$317
Daiichi Sankyo Inc.
$229
Merck Sharp & Dohme Corporation
$194
Sunovion Pharmaceuticals Inc.
$180
Allergan, Inc.
$167
SANOFI-AVENTIS U.S. LLC
$152
ABBVIE INC.
$151
Eisai Inc.
$143
COMSORT, Inc
$100
Esperion Therapeutics, Inc.
$91
Axsome Therapeutics, Inc.
$84
Supernus Pharmaceuticals, Inc.
$83
Synergy Pharmaceuticals Inc
$76
Abbott Laboratories
$74
IDORSIA PHARMACEUTICALS US INC
$71
Xeris Pharmaceuticals, Inc.
$65
Astellas Pharma US Inc
$60
Bayer Healthcare Pharmaceuticals Inc.
$46
UCB, Inc.
$44
Bayer HealthCare Pharmaceuticals Inc.
$41
Circassia Pharmaceuticals Inc
$31
Medtronic, Inc.
$30
Upsher-Smith Laboratories LLC
$30
Nestle HealthCare Nutrition Inc.
$27
Purdue Pharma L.P.
$27
E.R. Squibb & Sons, L.L.C.
$26
Allergan Inc.
$26
DEXCOM, INC.
$26
ITI, Inc.
$24
Azurity Pharmaceuticals, Inc.
$24
Ardelyx, Inc.
$21
Ultragenyx Pharmaceutical Inc.
$20
Harmony Biosciences LLC
$19
Biohaven Pharmaceutical Holding Company Ltd.
$19
Dexcom, Inc.
$17
Lundbeck LLC
$17
Shire North American Group Inc
$17
DERMIRA, INC.
$15
AbbVie, Inc.
$12
Sumitomo Pharma America, Inc.
$8
Top 3 companies account for 35.8% of all-time payments
Associated products mentioned in payments ›
ADVAIR · AIRSUPRA · ANORO · ANORO ELLIPTA · APTIOM · Aimovig · Auvelity · BELSOMRA · BEVESPI AEROSPHERE · BREO · BREZTRI · BREZTRI AEROSPHERE · BRILINTA · BROVANA · BYDUREON · Briviact · CAPLYTA · CHANTIX · CREON · Creon · Crysvita · DEXCOM G6 TRANSMITTER · Dayvigo · Dexcom G6 Transmitter · ELIQUIS · ENTRESTO · EVENITY · FARXIGA · FASENRA · FREESTYLE LIBRE 2 · FREESTYLE LIBRE 3 · FreeStyle Libre 2 · GATTEX · GEMTESA · GVOKE PFS · IBSRELA · INJECTAFER · INTELLIS ADAPTIVESTIM · InPen · JANUVIA · JARDIANCE · KEVEYIS · Kerendia · LEQVIO · LINZESS · LIVALO · LOKELMA · LONHALA MAGNAIR · LYRICA · Livalo · MOTEGRITY · MOUNJARO · MOVANTIK · MYRBETRIQ · Motegrity · Myrbetriq · NEXLETOL · NORTHERA · NURTEC ODT · Nayzilam · Ozempic · PREVNAR - 13 · Perforomist · Prolia · QBREXZA · QUDEXY XR Topiramate Extended Release Capsules · QULIPTA · QUVIVIQ · RYBELSUS · Repatha · Rybelsus · SEGLENTIS · SIVEXTRO · SOLIQUA · SOLIQUA 100/33 · SPIRIVA RESPIMAT · SPRAVATO · STIOLTO RESPIMAT · SYMBICORT · SYMPROIC · Saxenda · Seglentis · TOUJEO · TRADJENTA · TRELEGY ELLIPTA · TRINTELLIX · TROKENDI XR · TRULANCE · TRULICITY · TUDORZA PRESSAIR · Tresiba · Trintellix · Trulance · UBRELVY · Utibron · VRAYLAR · VYVANSE · Vascepa · Victoza · WAKIX · Wegovy · XARELTO · XIFAXAN · YUPELRI · Yupelri · ZENPEP · ZEPBOUND
Should you be concerned? Payments from pharmaceutical and device companies are legal and common — 57% of U.S. physicians receive at least one. They often reflect legitimate consulting, research, or education. What matters is whether a recommended drug or device appears in your doctor's payment records. If so, consider asking your doctor about it. How to interpret this data →
Most payments (98%) are for meals and travel — low-value interactions that are common across virtually all practicing physicians. Total industry engagement is in the top 2% for family medicine in IL.
Geographic Context
Family medicine physicians within 10 mi
31
Per 100K population
83.1
County median income
$60,839
Nearest hospital
SSM HEALTH ST MARY'S HOSPITAL -CENTRALIA
0.0 mi
0.0 mi
Data Sources
| Provider Registry | ✓ NPPES | Weekly updates |
| Medicare Enrollment | ✓ PECOS | Monthly updates |
| Practice Data | ✓ Medicare Util. | Annual (CY lag) |
| Industry Payments | ✓ Open Payments | CY 2024 |
| Disciplinary History | — Not public | N/A |
This provider has data in 4 of 4 available federal datasets, with a Data Coverage level of Very High. This reflects how much public data is available about a provider. How we calculate this →
Summary
Dr. Shrestha is a clinical cardiology specialist, with above-average Medicare volume (top 7% in IL), with low-engagement industry engagement in the top 2% of IL peers, with 18 years of NPI registration.
This summary is auto-generated from federal data, describing data availability and patterns. Read our methodology →
Frequently Asked Questions
Is Dr. Shrestha experienced with office visit, established patient (20-29 min)?
Based on Medicare claims data, Dr. Shrestha performed 754 office visit, established patient (20-29 min) services. Research suggests that higher procedure volume is often associated with better outcomes, particularly for complex procedures. Note that Medicare data only captures patients aged 65 and older, so the total practice volume across all patients is likely higher.
Does Dr. Shrestha receive payments from pharmaceutical companies?
Yes. Dr. Shrestha received a total of $13,187 from 54 companies across 838 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common among physicians — 57% of all U.S. physicians receive at least one industry payment. Patients may wish to ask their doctor about these relationships, especially if a recommended drug or device appears in the payment records.
How do Dr. Shrestha's costs compare to other family medicine physicians in Centralia?
Dr. Shrestha's average Medicare payment per service is $71. Note that these figures represent what Medicare pays, not your out-of-pocket cost, which depends on your specific insurance plan and deductible. Procedure-level data above shows both what was submitted and what Medicare paid for each service type.
What does Data Coverage mean?
Data Coverage (currently Very High for Dr. Shrestha) measures how much public federal data is available about a provider. It is not a quality rating. A "Very High" or "High" level means the provider has data across multiple federal sources (NPPES, PECOS, Medicare Utilization, Open Payments), indicating a long track record of practice, Medicare participation, and industry disclosure. A "Low" or "Moderate" level may simply mean the provider is newer, does not see Medicare patients, or has not received any industry payments — none of which are inherently negative. Read our full methodology →
Is this data up to date?
Each data source has its own update cycle. Provider registry data (NPPES) is updated weekly. Medicare enrollment (PECOS) is updated monthly. Medicare practice data has a ~2 year lag — the most recent available is typically 2 years prior. Industry payment data (Open Payments) is published annually, usually in June, covering the prior calendar year. We display the data date prominently on each section so you always know how current it is. See our data freshness policy →
Explore related providers
Specialty guide
Understanding Family Medicine
Common procedures, typical costs, and what industry payments mean in family medicine.
Same specialty & city
Family Medicine Physicians in Centralia
Browse family medicine physicians in Centralia ranked by procedure volume and transparency data.
Highest volume
Top Family Medicine Physicians in IL
Family medicine physicians ranked by total Medicare services performed statewide.
Industry payments
Pharma Payments to Family Medicine Physicians in IL
Which IL family medicine physicians receive the most from drug and device companies.
By company
AstraZeneca Pharmaceuticals LP Payments to Doctors
See all physicians who received payments from AstraZeneca Pharmaceuticals LP.
By company
GlaxoSmithKline, LLC. Payments to Doctors
See all physicians who received payments from GlaxoSmithKline, LLC.
By company
Lilly USA, LLC Payments to Doctors
See all physicians who received payments from Lilly USA, LLC.
About this page
All data on this page is sourced verbatim from public federal records published by the U.S. Centers for Medicare & Medicaid Services (CMS): NPPES ↗, Open Payments ↗, Medicare Provider Utilization ↗, and PECOS. Publication is mandated by the Physician Payments Sunshine Act (§6002 ACA, 42 U.S.C. §1320a-7h) and the Freedom of Information Act.
This page is not medical advice, an endorsement, a recommendation, or a quality rating. Data Coverage reflects data completeness — how much federal information exists for this provider — not clinical performance, patient outcomes, or quality of care. Always verify information directly with the provider and consult a licensed clinician before making medical decisions.
Provider corrections: Provider portal · Privacy questions: Privacy Policy · Terms: Terms of Use · Methodology: Methodology